Shafa M et al.Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers.Front Med (Lausanne) 5:69 (2018).
Green CJ et al.The isolation of primary hepatocytes from human tissue: optimising the use of small non-encapsulated liver resection surplus.Cell Tissue Bank 18:597-604 (2017).
Li Y et al.Abnormal Neural Progenitor Cells Differentiated from Induced Pluripotent Stem Cells Partially Mimicked Development of TSC2 Neurological Abnormalities.Stem Cell Reports 8:883-893 (2017).
Ahmadian Baghbaderani B et al.A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells.PLoS One 11:e0161229 (2016).
Zhang JW et al.miR-630 overexpression in hepatocellular carcinoma tissues is positively correlated with alpha-fetoprotein.Med Sci Monit 21:667-73 (2015).
Carpentieri A et al.Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor.Cell Death Dis 6:e1974 (2015).
Zhou H et al.Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.Stem Cell Rev 11:652-65 (2015).
Dinish US et al.Sensitive multiplex detection of serological liver cancer biomarkers using SERS-active photonic crystal fiber probe.J Biophotonics 7:956-65 (2014).
Nie Y et al.Scalable passaging of adherent human pluripotent stem cells.PLoS One 9:e88012 (2014).
Pettinato G et al.ROCK inhibitor is not required for embryoid body formation from singularized human embryonic stem cells.PLoS One 9:e100742 (2014).
Pettinato G et al.Formation of well-defined embryoid bodies from dissociated human induced pluripotent stem cells using microfabricated cell-repellent microwell arrays.Sci Rep 4:7402 (2014).
Colquhoun DR et al.Global screening of human cord blood proteomes for biomarkers of toxic exposure and effect.Environ Health Perspect 117:832-8 (2009).
Cavin LG et al.Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.Cancer Res 64:7030-8 (2004).
Stefanova I et al.Monoclonal antibodies against human alpha-fetoprotein. Exploitation of an unusual calcium-dependent interaction with the antigen for analytical and preparative purposes.J Immunol Methods 111:67-73 (1988).